Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president and CEO, purchased 20,467 shares of Lannett Company common stock in the open market on September 9, 2011. A Form 4 was filed today reflecting the purchase of the shares.

About Lannett Company, Inc.

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company’s website at www.lannett.com.

Copyright Business Wire 2010

If you liked this article you might like

Drug Companies Respond to States Generic Drug Lawsuit

Drug Companies Respond to States Generic Drug Lawsuit

Small Caps Continue to Outperform on Tax Reform, Oil Marches Higher - ICYMI

Small Caps Continue to Outperform on Tax Reform, Oil Marches Higher - ICYMI

Lannett Scores FDA OK for Nexium Generic-Biotech Movers

Lannett Scores FDA OK for Nexium Generic-Biotech Movers

Teva, Mylan Seen to Stay on M&A Sidelines

Teva, Mylan Seen to Stay on M&A Sidelines

Teva's Massive Debt Load Just Became an Even Bigger Issue

Teva's Massive Debt Load Just Became an Even Bigger Issue